A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Richard M. Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L. Baehner, Tea Fevr, Laura Clark, Nora Bayani, Jean Philippe Coppe, Frances Tong, Terry Speed, Paul T. Spellman, Sandy DeVries, Anna Lapuk, Nick J. Wang, Wen Lin Kuo, Jackie L. Stilwell, Daniel Pinkel, Donna G. Albertson, Frederic M. Waldman & 7 others Frank McCormick, Robert B. Dickson, Michael D. Johnson, Marc Lippman, Stephen Ethier, Adi Gazdar, Joe W. Gray

Research output: Contribution to journalArticle

1960 Citations (Scopus)

Abstract

Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events. Here, we describe a model "system" to appraise the functional contributions of these genes to breast cancer subsets. In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented. The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biological heterogeneity found in primary tumors. We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify molecular features that predict or indicate response to targeted therapies or other physiological perturbations.

Original languageEnglish (US)
Pages (from-to)515-527
Number of pages13
JournalCancer Cell
Volume10
Issue number6
DOIs
StatePublished - Dec 2006

Fingerprint

Breast Neoplasms
Cell Line
Neoplasms
Epigenomics
Genes
Trastuzumab
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., ... Gray, J. W. (2006). A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell, 10(6), 515-527. https://doi.org/10.1016/j.ccr.2006.10.008

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. / Neve, Richard M.; Chin, Koei; Fridlyand, Jane; Yeh, Jennifer; Baehner, Frederick L.; Fevr, Tea; Clark, Laura; Bayani, Nora; Coppe, Jean Philippe; Tong, Frances; Speed, Terry; Spellman, Paul T.; DeVries, Sandy; Lapuk, Anna; Wang, Nick J.; Kuo, Wen Lin; Stilwell, Jackie L.; Pinkel, Daniel; Albertson, Donna G.; Waldman, Frederic M.; McCormick, Frank; Dickson, Robert B.; Johnson, Michael D.; Lippman, Marc; Ethier, Stephen; Gazdar, Adi; Gray, Joe W.

In: Cancer Cell, Vol. 10, No. 6, 12.2006, p. 515-527.

Research output: Contribution to journalArticle

Neve, RM, Chin, K, Fridlyand, J, Yeh, J, Baehner, FL, Fevr, T, Clark, L, Bayani, N, Coppe, JP, Tong, F, Speed, T, Spellman, PT, DeVries, S, Lapuk, A, Wang, NJ, Kuo, WL, Stilwell, JL, Pinkel, D, Albertson, DG, Waldman, FM, McCormick, F, Dickson, RB, Johnson, MD, Lippman, M, Ethier, S, Gazdar, A & Gray, JW 2006, 'A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes', Cancer Cell, vol. 10, no. 6, pp. 515-527. https://doi.org/10.1016/j.ccr.2006.10.008
Neve, Richard M. ; Chin, Koei ; Fridlyand, Jane ; Yeh, Jennifer ; Baehner, Frederick L. ; Fevr, Tea ; Clark, Laura ; Bayani, Nora ; Coppe, Jean Philippe ; Tong, Frances ; Speed, Terry ; Spellman, Paul T. ; DeVries, Sandy ; Lapuk, Anna ; Wang, Nick J. ; Kuo, Wen Lin ; Stilwell, Jackie L. ; Pinkel, Daniel ; Albertson, Donna G. ; Waldman, Frederic M. ; McCormick, Frank ; Dickson, Robert B. ; Johnson, Michael D. ; Lippman, Marc ; Ethier, Stephen ; Gazdar, Adi ; Gray, Joe W. / A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. In: Cancer Cell. 2006 ; Vol. 10, No. 6. pp. 515-527.
@article{a320c00a24374e2d9b1d6d4c9ca75f1a,
title = "A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes",
abstract = "Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events. Here, we describe a model {"}system{"} to appraise the functional contributions of these genes to breast cancer subsets. In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented. The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biological heterogeneity found in primary tumors. We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify molecular features that predict or indicate response to targeted therapies or other physiological perturbations.",
author = "Neve, {Richard M.} and Koei Chin and Jane Fridlyand and Jennifer Yeh and Baehner, {Frederick L.} and Tea Fevr and Laura Clark and Nora Bayani and Coppe, {Jean Philippe} and Frances Tong and Terry Speed and Spellman, {Paul T.} and Sandy DeVries and Anna Lapuk and Wang, {Nick J.} and Kuo, {Wen Lin} and Stilwell, {Jackie L.} and Daniel Pinkel and Albertson, {Donna G.} and Waldman, {Frederic M.} and Frank McCormick and Dickson, {Robert B.} and Johnson, {Michael D.} and Marc Lippman and Stephen Ethier and Adi Gazdar and Gray, {Joe W.}",
year = "2006",
month = "12",
doi = "10.1016/j.ccr.2006.10.008",
language = "English (US)",
volume = "10",
pages = "515--527",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

AU - Neve, Richard M.

AU - Chin, Koei

AU - Fridlyand, Jane

AU - Yeh, Jennifer

AU - Baehner, Frederick L.

AU - Fevr, Tea

AU - Clark, Laura

AU - Bayani, Nora

AU - Coppe, Jean Philippe

AU - Tong, Frances

AU - Speed, Terry

AU - Spellman, Paul T.

AU - DeVries, Sandy

AU - Lapuk, Anna

AU - Wang, Nick J.

AU - Kuo, Wen Lin

AU - Stilwell, Jackie L.

AU - Pinkel, Daniel

AU - Albertson, Donna G.

AU - Waldman, Frederic M.

AU - McCormick, Frank

AU - Dickson, Robert B.

AU - Johnson, Michael D.

AU - Lippman, Marc

AU - Ethier, Stephen

AU - Gazdar, Adi

AU - Gray, Joe W.

PY - 2006/12

Y1 - 2006/12

N2 - Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events. Here, we describe a model "system" to appraise the functional contributions of these genes to breast cancer subsets. In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented. The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biological heterogeneity found in primary tumors. We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify molecular features that predict or indicate response to targeted therapies or other physiological perturbations.

AB - Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events. Here, we describe a model "system" to appraise the functional contributions of these genes to breast cancer subsets. In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented. The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biological heterogeneity found in primary tumors. We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify molecular features that predict or indicate response to targeted therapies or other physiological perturbations.

UR - http://www.scopus.com/inward/record.url?scp=33845209913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845209913&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2006.10.008

DO - 10.1016/j.ccr.2006.10.008

M3 - Article

VL - 10

SP - 515

EP - 527

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 6

ER -